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Conclusion: The method of DSMS analysis allowed to assess 
new local-dose descriptors that might be better correlated 
with tox and promises to find important applications in 
investigating urinary tox. The incorporation of the found local 
dose predictors into multi-variable models including clinical 
predictors is currently in progress. 
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Purpose or Objective: Current models for the prediction of 
xerostomia and sticky saliva after radiotherapy (RT) are 
based on clinical and dosimetric information. Our hypothesis 
is that such models can be improved by the addition of 
patient-specific characteristics, quantified in CT image 
biomarkers (IBMs). The aim of this study is to improve the 
performance of prediction models for patient-rated 
moderate-to-severe xerostomia (Xer12m) and sticky saliva 
(STIC12m) 12 months after radiotherapy with the addition of 
these IBMs obtained from CT images before the start of RT. 
 
Material and Methods: Head and neck cancer patients were 
primarily treated with RT alone or in combination with 
systemic treatment. The patient rated complications were 
prospectively collected (EORTC QLQ-H&N35).The potential 
CT IBMs represent geometric (20), CT intensity (24) and 
pattern characteristics (88) of the CT-image of the parotid 
(PG) and submandibular (SG) glands. Furthermore, 
Xerbaseline, tumour, patient characteristics and mean doses 
to contra- and ipsi-lateral PG and SG were 
considered.Variables were preselected by omitting the least 
prognostic variable if inter-variable correlation was larger 
than 0.80. Lasso regularisation was used to create 
multivariable logistic regression models with and without 
IBMs to predict patient rated moderate-to-severe Xer12m and 
Stic12m. A repeated 10-fold cross validation was used to 
determine the optimal regularization term lambda. The final 
models were internally validated by testing the models on 
bootstrapped data. 
 
Results: Of the 254 patients with follow-up information at 12 
months, 100 (39%) and 62 (24%) had moderate-severe 
xerostomia and sticky saliva, respectively. Pre-selection of 
variables resulted in a selection of 26 variables for XER12m 
and 28 variables for STIC12m. For xerostomia, the lasso 
regularization selected in addition to mean contra-lateral PG 
dose and Xerbaseline , the image biomarker “Short Run 
Emphasis” (SRE). This CT IBM quantifies the occurrence of 
short lengths of CT intensity repetitions and thereby 
indicates the homogeneity of the parotid tissue. For sticky 
saliva, the IBM maximum CT intensity of the submandibular 
gland was selected in addition to STICbaseline and mean dose 
to SGs. The maximum intensity of the SG was related with 
the intra-vascular contrast in the artery or vein supplying the 
SG.  
For the prediction of both Xer12m and STIC12m, the addition 
of the multivariable selected CT-IBMs improved the 
performance measures significantly compared to the models 
that were based on dose and baseline complaints only (table 
1). The models were stable when internally validated. 
 
 
 
Conclusion: Prediction of XER12m and STIC12m could be 
improved with CT derived IBMs. The IBM associated with 
XER12m, "short run emphasis", might be a measure of non 
functional fatty parotid tissue. The STIC12m IBM, maximum 
intensity was related with the submandibular vascularization. 
Both predictive IBMs might be independent measures of 
radiosensitivity of the PG and SG. 
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Purpose or Objective: Radiomics is a new emerging field in 
which machine-learning algorithms are applied to analyse and 
mine imaging features with the goal to individualize radiation 
therapy. The identification of an effective and robust 
machine-learning method through systematic evaluations is 
an important step towards stable and clinically relevant 
radiomic biomarkers. Thus far, only few studies have 
addressed this question. Therefore, we investigated different 
machine-learning approaches to develop a radiomic signature 
and compared those signatures regarding to their predictive 
power. 
 
Material and Methods: Two datasets of patients with UICC 
stage III/IV advanced head and neck squamous cell carcinoma 
(HNSCC) were used for training and validation (N=23 and 
N=20, respectively, NCT00180180, Zips et al. R&O 105: 21–28, 
2012). All patients underwent FMISO- and FDG-PET/CT scans 
at several time points. We defined 45 radiomic-based image 
features, which were extracted from the gross tumour 
volume, delineated in CT0/FDG-PET0 and FMISO-PET0 
(baseline; 0 Gy), FMISO-PET20 (end of week 2; 20 Gy) and 
CT40 (end of week 4; 40 Gy). Furthermore, we computed the 
delta features CT40/CT0 as well as FMISO-PET20/FMISO-
PET0, leading to 315 image features in total. Radiomic 
signatures were built for the endpoints local tumour control 
(LC) and overall survival (OS) based on a semi-automatic 
approach using Cox regression models (SA) and automatic 
methods using random forests (RF) as well as boosted Cox 
regression models (CB). All models are applied to continuous 
survival endpoint data and were trained on the training 
cohort using a repeated (50 times) 2-fold cross validation. 
The prognostic performance was evaluated on the validation 
cohort using the concordance index (CI). 
 
Results: The SA signature achieved the best prognostic 
performance for local tumour control (CI=0.93). Furthermore, 
the CB and RF signatures performed well in the validation 
cohort (CI=0.86 and CI=0.74, respectively). The signature for 
overall survival built by the RF model achieved the best 
performance (CI=0.91, compared to CI=0.87 by the CB model 
and CI=0.77 by the SA method). Figure 1 exemplarily shows 
Kaplan-Maier curves determined by the SA radiomic signature 
for both endpoints. The patients could be statistically 
significantly separated into a low and high risk survival group 
in the training (LC: p=0.015 and OS: p=0.023) and the 
validation cohorts (LC: p=0.003 and OS: p=0.001). 
 
 
Conclusion: Our evaluation reveals that the RF and the CB 
model yield the highest predictive performance for both 
endpoints. The obtained signatures and features will be 
tested for stability using further delineation datasets. The 
comparison of machine-learning methods within the 
Radiomics processing chain is one important step to increase 
the robustness of the results and standardization of methods. 
 
Proffered Papers: Physics 7: Treatment planning: 
optimisation algorithms  
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Purpose or Objective: To compare fully non-coplanar liver 
SBRT with: 1) VMAT and 2) VMAT plus a few computer-
optimized non-coplanar beams. Main endpoint was the 
highest feasible biologically effective dose (BED) to the 
tumor within hard OAR constraints. 
 
Material and Methods: In our institution, liver metastases are 
preferentially treated with 3 fractions of 20 Gy. If not 
feasible for OAR constraints, the total dose of 60Gy is 
delivered in either 5 or 8 fractions. Assuming a tumor a/b of 
10 Gy, the tumor BEDs for 3x20 Gy, 5x12 Gy, and 8x7.5 Gy 
are 180 Gy, 132 Gy, and 105 Gy, respectively. For fifteen 
patients with liver metastases we generated (i) plans with 15-
25 computer-optimized non-coplanar IMRT beams (fully NC), 
(ii) VMAT plans, and (iii) plans combining VMAT with a few 
optimized non-coplanar IMRT beams (VMAT+NC). All plans 
were generated using our platform for fully automated multi-
criterial treatment planning including beam angle 
optimization, based on the in-house iCycle optimizer and 
Monaco (Elekta AB, Stockholm, Sweden). For each patient 
and treatment technique we established the lowest number 
of feasible treatment fractions, i.e. 3, 5 or 8 to achieve 
highest possible tumor BED. All generated plans were 
clinically deliverable at our linear accelerators (Elekta AB, 
Stockholm, Sweden). 
 
Results: Using 15-25 computer-optimized non-coplanar IMRT 
beams, 12 of the 15 patients (80%) could be treated with 3 
fractions, one patient (7%) with 5 fractions, and two patients 
(13%) with 8 fractions. With VMAT only, achievable tumor 
BEDs were considerably lower for 1/3 of the patients, for 5 
patients the fraction number needed to be increased to 
protect OARs: for 4 patients from 3 to 5 and for 1 from 5 to 8 
(Table). Otherwise the healthy liver constraint (1 patient), or 
the constraint for the stomach (2 patients), bowel (1 patient) 
or oesophagus (1 patient) would be exceeded. With 
VMAT+NC, for all 5 patients this could be fully restored, 
resulting in the same low fraction numbers as for fully NC 
(Table). Contributions of the added NC IMRT beams to the 
PTV mean dose were relatively high: one patient needed a 
single IMRT beam with a weight of 14.8%, 1 patient needed 2 
IMRT beams with a total weight of 39.9%, 2 patients required 
3 IMRT beams with total weights of 45.5% and 47.7%, and 1 
patient had 4 IMRT beams with a total weight of 46.1%. 
 
 
